InvestorsHub Logo
Followers 58
Posts 10179
Boards Moderated 1
Alias Born 09/21/2016

Re: Reyeton post# 105545

Thursday, 05/18/2017 5:50:39 PM

Thursday, May 18, 2017 5:50:39 PM

Post# of 463752
There are seemingly obvious contradictions here. If A2-73 has as much potential as many of us believe then what are we (or they) missing? Either the published reports by AVXL are complete fabrications or they really have for the first time ever shown evidence of effective CNS treatment, at least for AD. BTW, all the rest have always failed so it's not like the results are so ambiguous that failure is not measureable. Smart people have trialed and tested their asses off for 40 years and they all failed (99.6%).

Why would Biogen not buy in. Agree, times up.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News